Racial variation in autosomal dominant polycystic kidney disease

被引:18
作者
Freedman, BI
Soucie, JM
Chapman, A
Krisher, J
McClellan, WM
机构
[1] Wake Forest Univ, Sch Med, Dept Internal Med Nephrol, Winston Salem, NC 27157 USA
[2] Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA
[3] Emory Univ, Sch Med, Dept Internal Med Nephrol, Atlanta, GA USA
[4] SE Kidney Council Inc, ESRD Network 6, Raleigh, NC USA
[5] Emory Univ, Sch Med, Dept Internal Med, Atlanta, GA USA
[6] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA
关键词
autosomal dominant polycystic kidney disease (ADPKD); end-stage renal disease (ESRD); chronic kidney failure; race; blacks; familial clustering;
D O I
10.1016/S0272-6386(00)70298-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
These analyses were undertaken to determine whether racial variation contributes to the risk of end-stage renal disease (ESRD) in close relatives of incident dialysis patients with autosomal dominant polycystic kidney disease (ADPKD)-associated ESRD, A family history of ESRD was recorded in 14,769 incident ESRD patients in Network 6 (Georgia, North Carolina, South Carolina) between September 1993 and November 1997, Two hundred thirty-seven patients with ADPKD-ESRD comprised the study population (180 white and 57 black), Differences in patient populations were analyzed using the chi-squared and Student's t-tests, and multiple regression analysis was performed. Correlation in age at ESRD onset in families was performed by linear regression analysis. A positive family history (FH) of ESRD in first- or second-degree relatives was reported by 38.6% (22 of 57) of blacks and 55% (99 of 180) of whites (P = 0.03), The 22 blacks with a positive FH had a mean of 2.0 additional ESRD relatives and 10.4 total first-degree relatives, whereas the 99 whites with a positive FH had a mean of 2.6 additional ESRD relatives and 7.0 total first-degree relatives (P = 0.14 and P < 0.001, respectively). Mean age in years at first dialysis was similar in blacks and whites, regardless of FH (black FH positive, 63.8; black FH negative, 66.3; P = 0.66; white FH positive, 60.8; white FH negative, 62.8; P = 0.48), On average, 57.9% of the first- and second-degree relatives of white cases had ADPKD-associated ESRD, compared with 28.6% of the relatives of black cases (P < 0.001), In the multivariate analysis, white race (P = 0.004) and increasing family size (P = 0.002) were positively correlated with the number of relatives having ADPKD-associated ESRD, whereas age at ESRD onset (P = 0.50) and gender (P = 0.94) were not. Age at onset of ESRD was correlated within members of multiply affected white (P < 0.001) but not black families (P = 0.80), We conclude that blacks with ADPKD-associated ESRD are less likely than whites to have relatives with ESRD, and there is no correlation in age at onset of ADPKD-ESRD in black families. (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [31] Role of keratinocyte growth factor in the pathogenesis of autosomal dominant polycystic kidney disease
    Mei, CL
    Mao, ZG
    Shen, XF
    Wang, WJ
    Dai, B
    Tang, B
    Wu, YM
    Cao, Y
    Zhang, SZ
    Zhao, HD
    Sun, TM
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (11) : 2368 - 2375
  • [32] Pericardial Cyst: a Novel Extrarenal Manifestation of Autosomal Dominant Polycystic Kidney Disease
    Rock, Wasseem
    Mazen, Elias
    Saliba, Walid
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (10): : 630 - 631
  • [33] Multiple thoracic paraspinal meningeal cysts in autosomal dominant polycystic kidney disease
    Coche, E
    Persu, A
    Cosnard, G
    Quoidbach, A
    Pirson, Y
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (02)
  • [34] Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease
    Sharp, CK
    Zeligman, BE
    Johnson, AM
    Duley, I
    Gabow, PA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) : 863 - 868
  • [35] Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)
    Perrone, Ronald D.
    Neville, Jon
    Chapman, Arlene B.
    Gitomer, Berenice Y.
    Miskulin, Dana C.
    Torres, Vicente E.
    Czerwiec, Frank S.
    Dennis, Eslie
    Kisler, Bron
    Kopko, Steve
    Krasa, Holly B.
    LeRoy, Elizabeth
    Castedo, Juliana
    Schrier, Robert W.
    Broadbent, Steve
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (04) : 583 - 590
  • [36] Arterial dissections in autosomal dominant polycystic kidney disease - chance association or part of the disease spectrum?
    Nacasch, N.
    Werner, M.
    Golan, E.
    Korzets, Z.
    CLINICAL NEPHROLOGY, 2010, 73 (06) : 478 - 481
  • [37] Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan
    Higashihara, Eiji
    Nutahara, Kikuo
    Okegawa, Takatsugu
    Tanbo, Mitsuhiro
    Mori, Hideaki
    Miyazaki, Isao
    Nitatori, Toshiaki
    Kobayashi, Kuninori
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (04) : 746 - 752
  • [38] Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan
    Eiji Higashihara
    Kikuo Nutahara
    Takatsugu Okegawa
    Mitsuhiro Tanbo
    Hideaki Mori
    Isao Miyazaki
    Toshiaki Nitatori
    Kuninori Kobayashi
    Clinical and Experimental Nephrology, 2015, 19 : 746 - 752
  • [39] Rapid head growth in a baby with autosomal dominant polycystic kidney disease (ADPKD): Questions
    Shute, Rachel
    Jeelani, Owase
    Lee, Lucy
    Brennan, Eileen
    Bockenhauer, Detlef
    Barnicoat, Angela
    Shroff, Rukshana
    PEDIATRIC NEPHROLOGY, 2014, 29 (02) : 217 - 218
  • [40] Zebrafish Model as a Screen to Prevent Cyst Inflation in Autosomal Dominant Polycystic Kidney Disease
    Oliveira, Ines
    Jacinto, Raquel
    Pestana, Sara
    Nolasco, Fernando
    Calado, Joaquim
    Lopes, Susana Santos
    Roxo-Rosa, Monica
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)